Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Change in Accured Expenses (2016 - 2026)

Voyager Therapeutics' Change in Accured Expenses history spans 11 years, with the latest figure at -$3.2 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 216.71% to -$3.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.5 million, a 5.73% increase, with the full-year FY2025 number at -$2.5 million, up 5.73% from a year prior.
  • Change in Accured Expenses hit -$3.2 million in Q4 2025 for Voyager Therapeutics, down from $2.8 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for VYGR hit a ceiling of $5.8 million in Q4 2023 and a floor of -$9.3 million in Q1 2024.
  • Historically, Change in Accured Expenses has averaged -$131400.0 across 5 years, with a median of $422500.0 in 2021.
  • Biggest five-year swings in Change in Accured Expenses: soared 1065.84% in 2022 and later crashed 7527.05% in 2024.
  • Tracing VYGR's Change in Accured Expenses over 5 years: stood at -$423000.0 in 2021, then crashed by 1007.33% to -$4.7 million in 2022, then surged by 223.21% to $5.8 million in 2023, then tumbled by 52.71% to $2.7 million in 2024, then crashed by 216.71% to -$3.2 million in 2025.
  • Business Quant data shows Change in Accured Expenses for VYGR at -$3.2 million in Q4 2025, $2.8 million in Q3 2025, and $3.0 million in Q2 2025.